ChromaCode
Signal active
Organization
Contact Information
Overview
ChromaCode is a molecular diagnostics company focusing on bioinformatics. It leverages patented mathematical methods and algorithmic enhancements to enrich signal processing from life science instrumentation. The company uses this to extract new information on biochemistry reactions and substantially increase the performance capabilities of today’s gold-standard biochemical assays at a very low cost.
ChromaCode was founded in 2012, ChromaCode is headquartered in Carlsbad, California.
About
Industries
Biotechnology, Health Care, Health Diagnostics
Founded
2012
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
ChromaCode headquartered in United States, North America, operates in the Biotechnology, Health Care, Health Diagnostics sector. The company focuses on Biotechnology and has secured $6.8B in funding across 72 round(s). With a team of 51-100 employees, ChromaCode is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - ChromaCode, raised $12.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
6
Investors
3
Lead Investors
0
Total Funding Amount
$94.0M
Details
4
ChromaCode has raised a total of $94.0M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Late Stage Venture | 28.0M | ||
| 2020 | Late Stage Venture | 10.0M | ||
| 2023 | Late Stage Venture | |||
| 2017 | Early Stage Venture | 12.0M |
Investors
ChromaCode is funded by 27 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Jim Blair | - | FUNDING ROUND - Jim Blair | 12.0M |
| Domain Associates | - | FUNDING ROUND - Domain Associates | 12.0M |
| ChromaCode | - | FUNDING ROUND - ChromaCode | 12.0M |
| Okapi Venture Capital | - | FUNDING ROUND - Okapi Venture Capital | 12.0M |
Recent Activity
There is no recent news or activity for this profile.